Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib
Z Zhu, Q Zhu - Frontiers in Pharmacology, 2023 - frontiersin.org
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) play a crucial role in cancer treatment,
particularly in breast cancer, and their mechanism of drug resistance is a topic of global …
particularly in breast cancer, and their mechanism of drug resistance is a topic of global …
Predictors of self-care in patients with cancer treated with oral anticancer agents: A systematic review
S Ucciero, F Lacarbonara, A Durante, F Torino… - Plos one, 2024 - journals.plos.org
Background In the last two decades, the use of oral anticancer agents (OAAs) has increased
in cancer patients. Despite this, patients and their caregivers face some challenging issues …
in cancer patients. Despite this, patients and their caregivers face some challenging issues …
Analysis of the Relationship of Age, Gender, Education, Type of Cancer With the Level of Satisfaction and Compliance of One Day Care Chemotherapy Cancer …
C Hadi, M Isa, EM Sutrisna - 2024 - researchsquare.com
Background Patient satisfaction is an indicator of a hospital's standards and is a measure of
service quality. One day care (ODC) chemotherapy service is one of the service updates at …
service quality. One day care (ODC) chemotherapy service is one of the service updates at …
Effectiveness of nursing intervention designing protocol in improving knowledge and adherence among women with breastcancer regarding oral hormonal therapy
NF William, SES Abozead, ZAE Mohammad… - Assiut Scientific …, 2024 - journals.ekb.eg
Background: Oral hormonal medication is an essential part of the management of breast
cancer patients. Nurse intervention is important in the improvement of knowledge and the …
cancer patients. Nurse intervention is important in the improvement of knowledge and the …